Table 1 Clinical characteristics of patients with DM and Controls
| Â | DM patients n = 234 | Controls n = 121 | P-value |
|---|---|---|---|
Age, years | 56.5 ± 7.6 | 56.5 ± 8.4 | 0.99 |
Males, n (%) | 119 (51) | 59 (49) | 0.74 |
Hypertension, n (%) | 96 (41) | 18 (15) | < 0.01 |
Hypercholesterolemia, n (%) | 114 (49) | 24 (20) | < 0.01 |
Ever-smokers, n (%) | 72 (31) | 7 (6) | < 0.01 |
Duration of DM, yrs | 10.0 ± 8.0 | - |  |
Body-mass index, kg/m2 | 25.1 ± 4.7 | 21.5 ± 3.2 | < 0.01 |
Waist-hip circumference ratio | 0.9 ± 0.1 | 0.8 ± 0.1 | < 0.01 |
Body weight, kg | 64.6 ± 10.6 | 56.4 ± 9.1 | < 0.01 |
Systolic blood pressure, mmHg | 144.2 ± 21.2 | 118.8 ± 22.9 | < 0.01 |
Diastolic blood pressure, mmHg | 79.6 ± 8.8 | 72.3 ± 8.2 | < 0.01 |
Fasting blood glucose, mmol/L | 7.2 ± 2.2 | 4.9 ± 0.5 | < 0.01 |
HbA1c, % | 7.7 ± 1.5 | 5.8 ± 0.3 | < 0.01 |
Triglyceride, mmol/L | 1.6 ± 1.2 | 1.3 ± 0.9 | < 0.01 |
Total cholesterol, mmol/L | 4.6 ± 0.9 | 5.1 ± 0.8 | < 0.01 |
LDL-C, mmol/L | 2.6 ± 0.8 | 2.9 ± 0.7 | < 0.01 |
HDL-C, mmol/L | 1.3 ± 0.4 | 1.6 ± 0.4 | < 0.01 |
Creatinine, μmol/L | 84.6 ± 27.2 | 71.0 ± 16.6 | < 0.01 |
GFR, ml/min/1.73m2 | 55.4 ± 15.3 | 60.0 ± 13.7 | < 0.01 |
Beta-blocker, n (%) | 106 (45%) | 10 (8%) | < 0.01 |
Calcium channel blocker, n (%) | 77 (33%) | 3 (2%) | < 0.01 |
ACEI/ARB, n (%) | 122 (52%) | 6 (5%) | < 0.01 |
Aspirin, n (%) | 103 (44%) | 9 (7%) | < 0.01 |
Statin, n (%) | 119 (51%) | 9 (7%) | < 0.01 |
Insulin, n (%) | 35 (15%) | 0 (0%) | < 0.01 |
Log CD34/KDR+ EPCs, 10-3/ml | 0.96 ± 0.31 | 1.23 ± 0.36 | < 0.01 |
Log CD133/KDR+ EPCs, 10-3/ml | 0.70 ± 0.26 | 1.13 ± 0.38 | < 0.01 |
Log baPWV, cm/s | 3.24 ± 0.08 | 3.18 ± 0.09 | < 0.01 |